bethanechol has been researched along with Lymphoma of Mucosa-Associated Lymphoid Tissue in 1 studies
Bethanechol: A slowly hydrolyzing muscarinic agonist with no nicotinic effects. Bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, HEART RATE changes, and BRONCHIAL SPASM.
bethanechol : The carbamic acid ester of 2-methylcholine. A slowly hydrolysed muscarinic agonist with no nicotinic effects, it is used as its chloride salt to increase smooth muscle tone, as in the gastrointestinal tract following abdominal surgery, treatment of gastro-oesophageal reflux disease, and as an alternative to catheterisation in the treatment of non-obstructive urinary retention.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The bilateral truncal vagotomy significantly suppressed the restraint-induced gastric ulcer formation in rats, while bethanechol, and 6-hydroxydopamine led to an increase of the gastric ulcer formation." | 4.98 | MALT Lymphoma, Stress Ulcer and Cholinergic Nerves from the Viewpoint of Bilateral and Unilateral Truncal Vagotomy and Substance P. ( Kodama, Y; Matsui, H; Murasato, F; Murayama, SY; Nakamura, M; Overby, A; Sasaki, K; Takahashi, S, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kodama, Y | 1 |
| Sasaki, K | 1 |
| Murasato, F | 1 |
| Overby, A | 1 |
| Takahashi, S | 1 |
| Murayama, SY | 1 |
| Matsui, H | 1 |
| Nakamura, M | 1 |
1 review available for bethanechol and Lymphoma of Mucosa-Associated Lymphoid Tissue
| Article | Year |
|---|---|
MALT Lymphoma, Stress Ulcer and Cholinergic Nerves from the Viewpoint of Bilateral and Unilateral Truncal Vagotomy and Substance P.
Topics: Animals; Bethanechol; Cholinergic Neurons; Humans; Lymphoma, B-Cell, Marginal Zone; Oxidopamine; Sto | 2018 |